Traditional Chinese medicine composition with lipid-lowering effect as well as preparation method and application of traditional Chinese medicine composition
By reasonably combining traditional Chinese medicine compositions prepared with traditional Chinese medicine materials, the problem of limited effects of existing traditional Chinese medicine compositions in the field of lipid-lowering is solved, effective treatment of non-alcoholic fatty liver and hyperlipidemia is achieved, and blood lipid levels are significantly reduced. Improves liver health.
Patent Information
- Application Number
- CN202411354790.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-27
- Publication Date
- 2024-12-06
AI Technical Summary
The existing traditional Chinese medicine compositions have limited effect in the field of lipid-lowering, especially for the treatment of non-alcoholic fatty liver and hyperlipidemia, and traditional drugs are prone to cause side effects.
A Chinese medicine composition is prepared by reasonably combining Polygonum multiflorum, hawthorn, Salvia miltiorrhiza, lotus leaves, coix seed, Alisma, Knotweed, Cassia seed, Polygonatum, Murata leaves, Sugar Fritillaria and Fritillaria , etc., and is boiled and concentrated by adding water. Made into Chinese herbal ointments or granules to lower serum cholesterol and triglyceride levels and improve fatty liver and hyperlipidemia.
It significantly improved the therapeutic effect on fatty liver and hyperlipidemia, reduced the serum total cholesterol and triglyceride levels, reduced liver and spleen damage, increased HDL content and reduced LDL content, and had good lipid-lowering and Liver protection effect.
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of Chinese medicine preparations, and in particular to a Chinese medicine composition with lipid-lowering effect and a preparation method and application thereof. Background Art
[0002] Hyperlipidemia is an endocrine disease with an insidious onset. It is caused by high blood lipids due to unhealthy lifestyle and dietary habits and congenital genetic factors. Blood lipids are a general term for cholesterol, triglycerides (TG) and lipids (such as phospholipids) in serum. The blood lipids closely related to clinical practice are mainly cholesterol and triglycerides. Cholesterol in the human body mainly exists in the form of free cholesterol and cholesterol esters. Triglycerides are formed when the three hydroxyl groups in the glycerol molecule are esterified by fatty acids. Blood lipids are insoluble in water and must be combined with special proteins, namely apolipoproteins, to form lipoproteins in order to dissolve in the blood and be transported to tissues for metabolism. The basic items of blood lipid testing in clinical practice are total cholesterol (TC), triglycerides (TG), etc. At present, the main lipid-lowering drugs used in clinical practice are niacin, statins, fibrates, etc. These drugs are highly irritating to the stomach, liver, etc., and are prone to cause side effects such as gastrointestinal discomfort and liver and kidney damage.
[0003] Fatty liver is a disease characterized by excessive fat storage and fatty degeneration in liver cells. Many factors such as alcoholism and obesity can lead to the occurrence of this disease. Patients are often asymptomatic, and a few may experience fatigue, mild discomfort in the right upper abdomen, dull pain in the liver area, or upper abdominal distension and pain. Fatty liver is a reversible disease, and early diagnosis and timely treatment can often restore normalcy.
[0004] At present, Chinese medicine prescriptions have attracted attention in the field of lipid reduction due to their safety. For example, Chinese patent CN102488798A discloses a drug for treating non-alcoholic fatty liver disease, which is composed of an effective ingredient and a medically acceptable auxiliary material, characterized in that the effective ingredient is made of the following raw materials in parts by weight: 25-35 parts of raw hawthorn, 10-30 parts of Polygonum multiflorum, 10-30 parts of Cassia seed, 10-30 parts of Salvia miltiorrhiza, 10-20 parts of Polygonum cuspidatum, 10-20 parts of Atractylodes macrocephala, 10-20 parts of Orientalis, and 10-15 parts of Bupleurum. The drug described in the invention has the effects of promoting digestion and dispersing blood stasis, strengthening the spleen and resolving phlegm, soothing the liver and activating blood circulation, clearing away heat and removing dampness, and can be used for the treatment of non-alcoholic fatty liver disease such as obesity, fatigue, chest and flank pain, loss of appetite and yellow urine.
[0005] Chinese patent CN116637166A discloses a Chinese medicine composition for effectively lowering blood lipids and protecting the liver and its application, wherein the Chinese medicine composition comprises 5-10 parts of raw coix seeds, 1-2 parts of nutmeg, 3-7 parts of tangerine peel, 1-2 parts of perilla seeds, 3-7 parts of radish seeds, 3-7 parts of tuckahoe, 5-10 parts of lotus leaves, 5-10 parts of raw hawthorn, 2-5 parts of cinnamon, 5-10 parts of kudzu root, 5-12 parts of kelp, 3-7 parts of cassia seeds, 1-2 parts of amomum villosum, wherein nutmeg is Yunnan authentic Chinese medicinal materials, this Chinese medicine composition can significantly reduce the levels of total cholesterol and triglycerides in serum; after being boiled into a Chinese medicine paste and used for 16 days, it can restore the levels of total cholesterol and triglycerides in the serum of patients with mixed hyperlipidemia to normal levels, achieving the effect of treating mixed hyperlipidemia, and at the same time can relieve damage to the liver and spleen, has the effect of protecting the liver and spleen, and can also increase serum HDL content and reduce LDL content, which is beneficial for preventing cardiovascular diseases caused by hyperlipidemia.
[0006] At present, there are few Chinese medicine compositions with good lipid-lowering effects, and the lipid-lowering effects are limited. In view of this, the present invention optimizes the Chinese medicine formula to further improve the lipid-lowering effect, and has a good therapeutic effect on fatty liver, especially non-alcoholic fatty liver and hyperlipidemia. Summary of the invention
[0007] In view of this, the purpose of the present invention is to provide a Chinese medicine composition with lipid-lowering effect and its preparation method and application, through the reasonable compatibility between Chinese medicinal materials and synergistic enhancement, to achieve a good therapeutic effect on fatty liver and hyperlipidemia.
[0008] To achieve the above-mentioned object of the invention, the technical solution of the present invention is as follows:
[0009] On the one hand, the present invention provides a traditional Chinese medicine composition with lipid-lowering effect, comprising: Polygonum multiflorum, hawthorn, salvia miltiorrhiza, lotus leaf, coix seed, oriental water plantain, knotweed, cassia seed, polygonatum, mulberry leaf, selfheal and fritillaria thunbergii.
[0010] The formula of the present invention is explained as follows: processed Polygonum multiflorum nourishes the liver and kidneys, strengthens the tendons and bones, removes fat and reduces turbidity, and is the main ingredient. Crataegus and Salvia miltiorrhiza promote blood circulation, remove blood stasis and reduce fat, while lotus leaves clear away heat, remove dampness and reduce fat, and the three help the main ingredient and serve as the minister. Coix seeds and Rhizoma Alismatis strengthen the spleen and remove dampness, promote diuresis and remove turbidity, Polygonum cuspidatum removes dampness and removes blood stasis, resolves phlegm and detoxifies, Cassia seeds clear the liver, moisten the intestines and relieve constipation, Polygonatum sibiricum nourishes the liver and kidneys, and mulberry leaves, Prunella vulgaris and Fritillaria thunbergii clear the liver and reduce fire, soften and disperse nodules, and the eight medicines serve together as adjuvants. All the medicines are used together to achieve the functions of removing phlegm, reducing turbidity and removing blood stasis, and are used for fatty liver and hyperlipidemia.
[0011] Preferably, the Chinese medicine composition comprises, by weight: 250-380 parts of Polygonum multiflorum, 250-380 parts of Hawthorn, 200-300 parts of Salvia miltiorrhiza, 200-300 parts of Lotus leaf, 200-300 parts of Coix seed, 200-300 parts of Alisma orientalis, 150-230 parts of Polygonum cuspidatum, 200-300 parts of Cassia seed, 200-300 parts of Polygonatum sibiricum, 200-300 parts of mulberry leaf, 200-300 parts of Prunella vulgaris and 200-300 parts of Fritillaria thunbergii.
[0012] Further preferably, the Chinese medicine composition comprises, by weight: 290-350 parts of Polygonum multiflorum, 290-350 parts of Hawthorn, 230-280 parts of Salvia miltiorrhiza, 230-280 parts of Lotus leaf, 230-280 parts of Coix seed, 230-280 parts of Alisma orientalis, 170-210 parts of Polygonum cuspidatum, 230-280 parts of Cassia seed, 230-280 parts of Polygonatum sibiricum, 230-280 parts of mulberry leaf, 230-280 parts of Prunella vulgaris and 230-280 parts of Fritillaria thunbergii.
[0013] Further preferably, the Chinese medicine composition comprises, by weight: 316.5 parts of Polygonum multiflorum, 316.5 parts of Crataegus, 253 parts of Salvia miltiorrhiza, 253 parts of Lotus leaf, 253 parts of Coix seed, 253 parts of Alisma orientalis, 190 parts of Polygonum cuspidatum, 253 parts of Cassia seed, 253 parts of Polygonatum sibiricum, 253 parts of mulberry leaf, 253 parts of Prunella vulgaris and 253 parts of Fritillaria thunbergii.
[0014] Preferably, the Polygonum multiflorum is processed Polygonum multiflorum.
[0015] Preferably, the Cassia seeds are stir-fried Cassia seeds.
[0016] Preferably, the polygonatum is polygonatum odoratum.
[0017] In another aspect, the present invention provides a method for preparing the above-mentioned Chinese medicine composition, comprising the following steps:
[0018] The Chinese medicine composition is prepared by adding water to the formula amount of Polygonum multiflorum, hawthorn, salvia miltiorrhiza, lotus leaf, coix seed, oriental rhizome, polygonum cuspidatum, cassia seed, polygonatum sibiricum, mulberry leaf, selfheal and thunbergia thunbergii, filtering, combining the filtrate and concentrating.
[0019] Preferably, the number of times of decocting with water is 1-3 times, more preferably 2 times.
[0020] More preferably, the first time adding 10-15 times the amount of water is boiled for 0.5-2 hours, the second time adding 8-12 times the amount of water is boiled for 0.5-2 hours, and most preferably, the first time adding 12 times the amount of water is boiled for 1.0 hour, the second time adding 9 times the amount of water is boiled for 1.0 hour.
[0021] In yet another aspect, the present invention provides a medicine comprising the above-mentioned Chinese medicine composition.
[0022] The dosage form of the drug is selected from any one of the dosage forms such as pills, capsules, granules, oral liquids, powders, decoctions, tablets, lozenges, etc., and a suitable drug carrier in the art can be selected for different dosage forms.
[0023] The pharmaceutical carrier used can be solid, liquid or gas. Examples of solid carriers include lactose, kaolin, sucrose, talc, gelatin, agar, pectin, gum arabic, magnesium stearate and stearic acid. Examples of liquid carriers include syrup, peanut oil, olive oil and water. Examples of gaseous carriers include carbon dioxide and nitrogen.
[0024] When preparing the composition for oral dosage form, any convenient pharmaceutical medium may be used. For example, water, ethanol, oil, alcohol, flavoring agent, preservative, coloring agent, etc. may be used to form oral liquid preparations such as suspensions and solutions; and carriers such as starch, sugars, microcrystalline cellulose, diluents, granulating agents, emulsifiers, lubricants, binders, disintegrants may be used to form oral solid preparations, such as powders, capsules and tablets. Tablets may be coated using standard aqueous or non-aqueous techniques.
[0025] Tablets containing the Chinese medicine composition of the present invention can be prepared by tableting or molding, and one or more auxiliary ingredients or adjuvants can be used. The active ingredient can be tableted in a free-flowing form (such as powder or granules) in an appropriate machine, and can be prepared by mixing with an adhesive, a lubricant, an inert diluent, a surfactant, and a dispersant. Molded tablets can be molded in an appropriate machine. Each tablet preferably contains about 0.05 mg to about 5 g of active ingredient, and each sachet or capsule preferably contains about 0.05 mg to about 5 g of active ingredient. For example, a preparation intended for oral administration to the human body may contain about 0.5 mg to about 5 g of active drug, mixed with an appropriate and convenient carrier material, which may account for about 5% to 95% of the total composition. The unit dosage form usually contains about 1 mg to about 2 g of active ingredient, usually 25 mg, 50 mg, 100 mg, 200 mg, 300 mg, 400 mg, 500 mg, 600 mg, 800 mg or 1000 mg.
[0026] The medicine of the present invention can also be in a form suitable for rectal administration, wherein the carrier is a solid. Preferably, the mixture is made into a unit dose suppository. Suitable carriers include cocoa butter and other materials commonly used in the art. Suppositories can be prepared by first forming a composition containing a softened or melted carrier, followed by cooling and shaping in a mold.
[0027] In addition to the above-mentioned carrier components, the above-mentioned pharmaceutical preparations may include (if applicable) one or more additional carrier components, such as diluents, buffers, flavoring agents, binders, surfactants, thickeners, lubricants, preservatives (including antioxidants), etc. In addition, other excipients may be added, such as lactose, starch, cellulose derivatives, magnesium stearate, stearic acid, colorants and flavoring agents, etc.
[0028] Preferably, the drug is in the form of granules.
[0029] In another aspect, the present invention provides a method for preparing the above granules, comprising the steps of:
[0030] The formula amount of Polygonum multiflorum, hawthorn, salvia miltiorrhiza, lotus leaf, coix seed, oriental rhizome, polygonum cuspidatum, cassia seed, polygonatum sibiricum, mulberry leaf, selfheal and thunbergia thunbergii is decocted in water, filtered, the filtrate is combined, concentrated, and dextrin is added to prepare granules.
[0031] Preferably, the number of times of decocting with water is 1-3 times, more preferably 2 times.
[0032] More preferably, the first time adding 10-15 times the amount of water is boiled for 0.5-2 hours, the second time adding 8-12 times the amount of water is boiled for 0.5-2 hours, and most preferably, the first time adding 12 times the amount of water is boiled for 1.0 hour, the second time adding 9 times the amount of water is boiled for 1.0 hour.
[0033] Preferably, the concentration is to concentrate to a relative density of 1.05-1.10 (60° C.).
[0034] As a specific example, the method comprises the following steps: the above twelve ingredients are decocted twice with water, the first time with 12 times the amount of water and decocted for 1.0 hour, the second time with 9 times the amount of water and decocted for 1.0 hour, the decoction is filtered, the filtrate is combined, and the decoction is concentrated under reduced pressure to a clear paste with a relative density of 1.05-1.10 (60°C), an appropriate amount of dextrin is added, mixed, dried, and then an appropriate amount of dextrin is added, mixed, and made into granules.
[0035] Finally, the present invention provides the use of the above composition, the composition obtained by the above preparation method or the above medicine in the preparation of lipid-lowering medicine, medicine for treating fatty liver or medicine for treating hyperlipidemia.
[0036] The beneficial effects of the present invention are:
[0037] The present invention achieves a good therapeutic effect on fatty liver and hyperlipidemia through reasonable compatibility and synergistic enhancement between Chinese medicinal materials. In the formula of the present invention, coix seed and orientalis play a synergistic role in strengthening the spleen and removing dampness, promoting diuresis and removing turbidity; mulberry leaf, selfheal and thunbergia play a synergistic role in clearing the liver and reducing fire. All the prescriptions can significantly improve the lipid-lowering effect under specific ratios. DETAILED DESCRIPTION
[0038] In order to make the technical means, creative features, purpose and efficacy of the present invention easy to understand, the present invention is further explained in conjunction with specific embodiments below, but the following embodiments are only preferred embodiments of the present invention, not all. Based on the embodiments in the implementation mode, other embodiments obtained by those skilled in the art without creative work all belong to the protection scope of the present invention. In the following embodiments, unless otherwise specified, the operating methods used are conventional operating methods, the equipment used are conventional equipment, and the equipment materials used in each embodiment are the same.
[0039] Prepared Polygonum multiflorum, processed products of Polygonum multiflorum. Take Polygonum multiflorum slices or pieces, mix them with black bean juice according to the stewing method (General Rules 0213 of the Fourth Part of the 2020 Edition of the Chinese Pharmacopoeia), put them in a suitable non-iron container, and stew until the juice is absorbed; or steam them according to the steaming method (General Rules 0213 of the Fourth Part of the 2020 Edition of the Chinese Pharmacopoeia), steam them or mix them with black bean juice and then steam them until they are brown inside and outside, or dry them in the sun until they are half dry, slice them, and dry them. For every 100kg of Polygonum multiflorum slices (pieces), use 10kg of black beans.
[0040] Hawthorn is the dried mature fruit of Crataegus pinnatifida Bge.var.major NEBr. or Crataegus pinnatifida Bge. of the Rosaceae family. The fruit is harvested in autumn when it is ripe, sliced and dried.
[0041] Salvia miltiorrhiza is the dried root and rhizome of Salvia miltiorrhiza Bge., a plant of the Lamiaceae family. It is dug up in spring and autumn, desilted, and dried.
[0042] Lotus leaf is the dried leaf of Nelumbo nucifera Gaertn., a plant of the Nymphaeaceae family. It is harvested in summer and autumn, and when it is 70% to 80% dry, the petiole is removed, folded into a semicircle or fan shape, and dried.
[0043] Job's tears are the dried mature kernels of Coix lacryma-jobi L. var. ma-yuen (Roman.) Stapf, a plant of the Poaceae family. When the fruits are ripe in autumn, the plants are harvested, sun-dried, the fruits are beaten, and then sun-dried. The shells, yellow-brown seed coats and impurities are removed, and the kernels are collected.
[0044] Alisma orientale, the dried tuber of Alisma orientale (Sam.) Juzep. or Alisma plantago-aquatica Linn. of the Alismataceae family. It is dug up in winter when the stems and leaves begin to wither, washed, dried, and the fibrous roots and rough bark are removed.
[0045] Polygonum cuspidatum Sieb.et Zucc. is a plant of the Polygonaceae family. It is a dried rhizome and root. It is dug up in spring and autumn, the fibrous roots are removed, it is washed, cut into short sections or thick slices while fresh, and dried in the sun.
[0046] Stir-fry Cassia Seed: Take clean Cassia Seed and stir-fry it according to the stir-fry method (Chinese Pharmacopoeia 2020 Edition Part 4 General Rules 0213) until it is slightly swollen and has fragrance. Crush it when using.
[0047] For Huangjing with wine, take clean Huangjing, stew or steam it thoroughly according to the wine stewing method or wine steaming method (Chinese Pharmacopoeia 2020 Edition Four General Rules 0213), let it dry for a while, cut into thick slices, and dry. For every 100kg of Huangjing, use 20kg of rice wine.
[0048] Mulberry leaves are the dried leaves of Morus alba L., a plant of the Moraceae family. They are harvested after the first frost, and then removed of impurities and sun-dried.
[0049] Prunella vulgaris, the dried fruit ears of Prunella vulgaris L., a plant of the Lamiaceae family. The fruit ears are harvested in summer when they are brown-red, and impurities are removed and the fruit ears are sun-dried.
[0050] Fritillaria thunbergii Miq., the dried bulb of Fritillaria thunbergii Miq., a plant of the Liliaceae family. Dig it up when the plant withers in early summer and wash it clean.
[0051] Example 1
[0052] The formula is: 316.5 parts of processed Polygonum multiflorum, 316.5 parts of hawthorn, 253 parts of Salvia miltiorrhiza, 253 parts of lotus leaves, 253 parts of coix seeds, 253 parts of Alisma orientalis, 190 parts of Polygonum cuspidatum, 253 parts of stir-fried Cassia seeds, 253 parts of Polygonatum sibiricum, 253 parts of mulberry leaves, 253 parts of Prunella vulgaris, and 253 parts of Fritillaria thunbergii.
[0053] Example 2
[0054] The formula is: 290 parts of processed Polygonum multiflorum, 350 parts of hawthorn, 230 parts of Salvia miltiorrhiza, 280 parts of lotus leaves, 280 parts of coix seeds, 280 parts of Alisma orientalis, 170 parts of Polygonum cuspidatum, 280 parts of stir-fried Cassia seeds, 230 parts of Polygonatum sibiricum, 280 parts of mulberry leaves, 230 parts of Prunella vulgaris, and 280 parts of Fritillaria thunbergii.
[0055] Example 3
[0056] The formula is: 350 parts of processed Polygonum multiflorum, 290 parts of hawthorn, 280 parts of Salvia miltiorrhiza, 230 parts of lotus leaves, 230 parts of coix seeds, 230 parts of Alisma orientalis, 210 parts of Polygonum cuspidatum, 230 parts of stir-fried Cassia seeds, 280 parts of Polygonatum sibiricum, 230 parts of mulberry leaves, 280 parts of Prunella vulgaris, and 230 parts of Fritillaria thunbergii.
[0057] Example 4
[0058] The formula is: 250 parts of processed Polygonum multiflorum, 380 parts of hawthorn, 300 parts of Salvia miltiorrhiza, 200 parts of lotus leaves, 300 parts of Coix seeds, 200 parts of Alisma orientalis, 230 parts of Polygonum cuspidatum, 300 parts of stir-fried Cassia seeds, 300 parts of wine Polygonatum, 200 parts of mulberry leaves, 300 parts of Prunella vulgaris, and 200 parts of Fritillaria thunbergii.
[0059] Example 5
[0060] The formula is: 380 parts of processed Polygonum multiflorum, 250 parts of hawthorn, 200 parts of Salvia miltiorrhiza, 300 parts of lotus leaves, 200 parts of coix seeds, 300 parts of Alisma orientalis, 150 parts of Polygonum cuspidatum, 200 parts of stir-fried Cassia seeds, 200 parts of wine Polygonatum, 300 parts of mulberry leaves, 200 parts of Prunella vulgaris, and 300 parts of Fritillaria thunbergii.
[0061] Comparative Example 1
[0062] The formula is: 450 parts of processed Polygonum multiflorum, 316.5 parts of hawthorn, 150 parts of salvia miltiorrhiza, 100 parts of lotus leaf, 253 parts of coix seed, 350 parts of oriental rhizome, 190 parts of polygonum cuspidatum, 150 parts of stir-fried cassia seed, 350 parts of wine polygonatum, 253 parts of mulberry leaf, 253 parts of selfheal, 253 parts of fritillaria thunbergii
[0063] Comparative Example 2
[0064] The formula is: 316.5 parts of processed Polygonum multiflorum, 316.5 parts of hawthorn, 253 parts of salvia miltiorrhiza, 253 parts of lotus leaf, 506 parts of oriental rhizome, 190 parts of polygonum cuspidatum, 253 parts of stir-fried cassia seed, 253 parts of wine polygonatum, 253 parts of mulberry leaf, 253 parts of selfheal, 253 parts of fritillaria thunbergii
[0065] Comparative Example 3
[0066] The formula is: 316.5 parts of processed Polygonum multiflorum, 316.5 parts of hawthorn, 253 parts of Salvia miltiorrhiza, 253 parts of lotus leaves, 506 parts of coix seeds, 190 parts of Polygonum cuspidatum, 253 parts of stir-fried Cassia seeds, 253 parts of wine Polygonatum, 253 parts of mulberry leaves, 253 parts of Prunella vulgaris, 253 parts of Fritillaria thunbergii
[0067] Comparative Example 4
[0068] The formula is: 316.5 parts of processed Polygonum multiflorum, 316.5 parts of hawthorn, 253 parts of Salvia miltiorrhiza, 253 parts of lotus leaves, 253 parts of coix seeds, 253 parts of oriental water plantains, 190 parts of polygonum cuspidatum, 253 parts of stir-fried cassia seeds, 253 parts of wine polygonatum, 253 parts of selfheal, and 506 parts of Fritillaria thunbergii.
[0069] Comparative Example 5
[0070] The formula is: 316.5 parts of processed Polygonum multiflorum, 316.5 parts of hawthorn, 253 parts of Salvia miltiorrhiza, 253 parts of lotus leaves, 253 parts of coix seeds, 253 parts of oriental water plantains, 190 parts of polygonum cuspidatum, 253 parts of stir-fried cassia seeds, 253 parts of wine polygonatum, 253 parts of mulberry leaves, and 506 parts of Fritillaria thunbergii.
[0071] Preparation Example
[0072] The above examples and comparative examples were prepared according to the following method:
[0073] Add water to the formula amount of Polygonum multiflorum, hawthorn, salvia miltiorrhiza, lotus leaf, coix seed, oriental rhizome, polygonum cuspidatum, cassia seed, polygonatum, mulberry leaf, selfheal and thunbergia thunbergii and boil twice, add 12 times the amount of water for the first time and boil for 1.0 hour, add 9 times the amount of water for the second time and boil for 1.0 hour, filter the decoction, combine the filtrate, and concentrate under reduced pressure to a clear paste with a relative density of 1.05-1.10 (60°C).
[0074] Results
[0075] Detection method: 120 healthy Kunming mice, half male and half female, weighing 18-22 g, were adaptively fed for 3 days and then randomly divided into groups according to body weight, with 10 mice in each group, namely, a normal group, a model group, Example 1-5 groups, and Comparative Example 1-5 groups.
[0076] The normal group continued to be fed with ordinary feed, and the other groups were fed with high-fat feed (basic feed: lard: sucrose: cholesterol: bile salt = 3:1:1:0.17:0.02) for 6 consecutive weeks to establish a non-alcoholic fatty liver model. Then, each medication group was gavaged with 20g crude drug / kg of the corresponding composition, with a dosing volume of 0.2mL / 10g, and the normal group and the model group were gavaged with an equal volume of distilled water, once a day, for 4 consecutive weeks.
[0077] The mice were fasted and deprived of water for 12 hours after the last administration. The mice in each group were killed 12 hours later, and blood was collected from the eyeballs. After being placed at room temperature for 2 hours, the blood was centrifuged at 3000 r / min for 10 minutes, and the supernatant was kept in a -20°C refrigerator.
[0078] According to the kit instructions, the levels of triglyceride (TG), total cholesterol (TC), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in mouse serum were detected.
[0079] Test results:
[0080] Table 1.
[0081] Group TG (mmoL / L) TC(mmoL / L) ALT(U / L) AST(U / L) Normal group 0.76±0.08 4.95±0.75 22.08±2.89 34.52±4.16 Model Group <![CDATA[2.05±0.62 ** ]]> <![CDATA[10.62±2.34 ** ]]> <![CDATA[41.18±4.52 ** ]]> <![CDATA[80.63±6.29 ** ]]> Example 1 <![CDATA[0.94±0.11 ## ]]> <![CDATA[5.16±1.05 ## ]]> <![CDATA[23.54±2.47 ## ]]> <![CDATA[35.13±4.31 ## ]]> Example 2 <![CDATA[1.01±0.07 ## ]]> <![CDATA[5.20±1.01 ## ]]> <![CDATA[24.16±2.76 ## ]]> <![CDATA[36.42±4.83 ## ]]> Example 3 <![CDATA[1.04±0.13 ## ]]> <![CDATA[5.28±0.96 ## ]]> <![CDATA[24.13±2.55 ## ]]> <![CDATA[36.25±5.08 ## ]]> Example 4 <![CDATA[1.12±0.14 ## ]]> <![CDATA[5.33±1.17 ## ]]> <![CDATA[24.89±3.02 ## ]]> <![CDATA[37.53±4.60 ## ]]> Example 5 <![CDATA[1.13±0.09 ## ]]> <![CDATA[5.35±1.15 ## ]]> <![CDATA[25.03±2.71 ## ]]> <![CDATA[37.55±5.11 ## ]]> Comparative Example 1 <![CDATA[1.20±0.16 ## ]]> <![CDATA[5.87±1.22 ## ]]> <![CDATA[26.97±3.42 ## ]]> <![CDATA[41.07±5.43 ## ]]> Comparative Example 2 <![CDATA[1.44±0.22 #△ ]]> <![CDATA[7.53±1.42 #△ ]]> <![CDATA[30.58±4.36 ##△ ]]> <![CDATA[48.98±5.18 ##△ ]]> Comparative Example 3 <![CDATA[1.44±0.18 #△ ]]> <![CDATA[7.56±1.47 #△ ]]> <![CDATA[31.12±3.69 ##△ ]]> <![CDATA[50.02±5.62 ##△ ]]> Comparative Example 4 <![CDATA[1.48±0.20 #△ ]]> <![CDATA[7.62±1.38 #△ ]]> <![CDATA[30.66±3.75 ##△ ]]> <![CDATA[49.56±4.96 ##△ ]]> Comparative Example 5 <![CDATA[1.46±0.23 #△ ]]> <![CDATA[7.58±1.21 #△ ]]> <![CDATA[31.05±4.14 ##△ ]]> <![CDATA[49.86±5.72 ##△ ]]>
[0082] Note: Compared with the normal group, ** P<0.01; compared with the model group, # P<0.05, ## P<0.01; Compared with Example 1, △ P<0.05.
[0083] The results show that the compositions prepared in Examples 1-5 and Comparative Example 1 have significant effects on reducing TG, TC, ALT, and AST, among which Example 1 has the best effect. Comparative Examples 2-5 do not add coix seeds, orientalis, mulberry leaves, and selfheal respectively. Although they also have different degrees of therapeutic effects, the effects are significantly reduced compared with Example 1, and there is a significant difference. In summary, the overall formula of the present application significantly improves the lipid-lowering and liver-protecting effects through the combination of various ingredients.
[0084] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims
1. A Chinese medicine composition having lipid-lowering effect, It is characterized in that include: Polygonum multiflorum, hawthorn, salvia miltiorrhiza, lotus leaf, coix seed, oriental water plantain, knotweed, cassia seed, polygonatum, mulberry leaf, selfheal and thunbergia thunbergii.
2. The Chinese medicine composition according to claim 1, It is characterized in that The invention comprises, by weight, 250-380 parts of Polygonum multiflorum, 250-380 parts of Hawthorn, 200-300 parts of Salvia miltiorrhiza, 200-300 parts of Lotus leaf, 200-300 parts of Coix seeds, 200-300 parts of Alisma orientalis, 150-230 parts of Polygonum cuspidatum, 200-300 parts of Cassia seed, 200-300 parts of Polygonatum sibiricum, 200-300 parts of mulberry leaf, 200-300 parts of Prunella vulgaris and 200-300 parts of Fritillaria thunbergii.
3. The Chinese medicine composition according to claim 2, It is characterized in that The ingredients include, by weight: 290-350 parts of Polygonum multiflorum, 290-350 parts of Hawthorn, 230-280 parts of Salvia miltiorrhiza, 230-280 parts of Lotus leaf, 230-280 parts of Coix seeds, 230-280 parts of Alisma orientalis, 170-210 parts of Polygonum cuspidatum, 230-280 parts of Cassia seed, 230-280 parts of Polygonatum sibiricum, 230-280 parts of mulberry leaf, 230-280 parts of Prunella vulgaris and 230-280 parts of Fritillaria thunbergii.
4. The Chinese medicine composition according to claim 3, It is characterized in that The ingredients include 316.5 parts of Polygonum multiflorum, 316.5 parts of Hawthorn, 253 parts of Salvia miltiorrhiza, 253 parts of Lotus leaf, 253 parts of Coix seed, 253 parts of Alisma orientalis, 190 parts of Polygonum cuspidatum, 253 parts of Cassia seed, 253 parts of Polygonatum sibiricum, 253 parts of mulberry leaf, 253 parts of Prunella vulgaris and 253 parts of Fritillaria thunbergii.
5. The Chinese medicine composition according to claim 1, It is characterized in that The Polygonum multiflorum is processed Polygonum multiflorum; the Cassia seed is stir-fried Cassia seed; and the Polygonatum sibiricum is wine-boiled Polygonatum sibiricum.
6. A method for preparing the Chinese medicine composition according to any one of claims 1 to 5, It is characterized in that The following steps are involved: The Chinese medicine composition is prepared by adding water to the formula amount of Polygonum multiflorum, hawthorn, salvia miltiorrhiza, lotus leaf, coix seed, oriental rhizome, polygonum cuspidatum, cassia seed, polygonatum sibiricum, mulberry leaf, selfheal and thunbergia thunbergii, filtering, combining the filtrate and concentrating.
7. The preparation method according to claim 6, It is characterized in that The decoction is as follows: adding 10-15 times the amount of water for the first time and decoct for 0.5-2 hours, and adding 8-12 times the amount of water for the second time and decoct for 0.5-2 hours.
8. A drug, It is characterized in that The invention comprises the Chinese medicine composition according to any one of claims 1 to 5.
9. The drug according to claim 8, It is characterized in that The dosage form of the drug is selected from any one of pills, capsules, granules, oral liquids, powders, decoctions, tablets, and lozenges.
10. Use of the composition according to any one of claims 1 to 5, the composition obtained by the preparation method according to claim 6 or 7, or the drug according to claim 8 or 9 in the preparation of lipid-lowering drugs, drugs for treating fatty liver, or drugs for treating hyperlipidemia.
Citation Information
Patent Citations
Medicine for treating non-alcoholic fatty liver
CN102488798A
Traditional Chinese medicine for treating fatty liver
CN103830560A
